Skip to content
Keratin 14 Filamentfärbung von Keratinozyten in grün, mit Plasmid transfizierte Zelle in rot 20x

Flexible funding needed?

Ad-hoc grants

This channel allows EB-ResNet and its potential grantholders to remain flexible and to respond in a timely manner to opportunities that arise, such as co-funding options, immediate need for funds, novel project ideas, or proof-of-concept projects.

Academic researchers, clinicians and also industry may approach EB-ResNet outside the scheduled research-proposal calls if there is an urgent need or a co-funding opportunity arises. This funding channel is only available while no research grant call is open. For example, an international or national funding scheme, a company or another patient group may offer funding schemes that also invite co-funding. Proposals more appropriate to scheduled research grant calls or industry co-funding, will be redirected.

No funding possibilities due to current Covid-19 pandemic.

Project scope 'Ad-hoc grants'

  • Fundamental to clinical research projects in EB
  • Quick funding/co-funding to respond to an opportunity arising in fundamental to preclinical research or a proof-of-concept project in EB
  • Lead applicant: researchers, clinicians, and/or industry partners (cooperation with industry welcome and possible)
  • Project duration: up to 12 months
  • Funding: up to EUR 100,000.00 p.a.

Application process

The application process has two steps. Informal application is done via a letter of interest (LOI) to office@eb-researchnetwork.org.

Please bear in mind that this funding channel is only available while no research grant is open - check under Research grants.

You will be informed whether your project fits into our funding scheme and if so, sent a link to our Grant Management online Application form.

General information: application and funding process

Funded ad-hoc grants

Ad-hoc grants

 

Project lead

Organisation/

Institute

Duration Research area EB-type Funder(s)
Ad-hoc 2020/2 Dr. Mattew Caley Queen Mary University London, UK 2 years Small molecules Junctional

DEBRA Austria

LifeArc Philantrophic Fund (UK)

Ad-hoc 2020/1

Prof. Dennis Roop,

Dr. Ganna Bilousova

University of Colorado, Denver,

USA

3 years

Preclinical

Simplex

 

DEBRA Austria

Vlinderkindje (B)

Ad-hoc 2019/1 Dr. Thomas Magin

University of Leipzig, Germany

1 year

Fever in EB

Simplex

 

DEBRA Austria

Tove Bruce (Sweden)

Ad-hoc 2019/2

DDr. Gudrun Salamon

Projectdetails

Sigmund Freud University, Austria 18 months

Quality of life,

Psychology

Simplex,

Dystrophic,

Junctional

DEBRA Austria
Ad-hoc 2017/1

Dr. Alexander Nyström,

Dr. Leena Bruckner-Tuderman

Projectdetails

University of Freiburg - Medical Center,

Departement of Dermatology, Germany

1 year

Preclinical, 

fibrosis

Dystrophic DEBRA Austria
Ad-hoc 2016/1 Prof. Dennis Roop

University of Colorado, Denver,

USA

2 years Preclinical Simplex

DEBRA Austria

Vlinderkindje (B)

 

Contact for Ad-hoc grants

Portraitfoto von Gaston Sendin

Gaston Sendin, PhD

Head of Research
Back to main navigation